Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Laura Rozenblum, M.D.

Concepts (73)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Positron-Emission Tomography12202464841.130 Why?
Glioma5202334550.970 Why?
Fluorodeoxyglucose F186202420090.850 Why?
Neuroendocrine Tumors220196410.850 Why?
Brain Neoplasms9202490320.780 Why?
Wernicke Encephalopathy12019290.660 Why?
Central Nervous System Neoplasms220249160.640 Why?
Treatment Failure1202426430.600 Why?
Intestinal Neoplasms120193140.560 Why?
Dihydroxyphenylalanine32023740.450 Why?
Amyloidosis120208170.430 Why?
Pancreatic Neoplasms2201953680.380 Why?
Brain Diseases1202015460.370 Why?
Magnetic Resonance Imaging112024364260.370 Why?
Radiopharmaceuticals6202426500.360 Why?
Stomach Neoplasms1201914590.330 Why?
Scedosporium12024100.240 Why?
Antineoplastic Combined Chemotherapy Protocols12024117420.220 Why?
Mycoses120243860.180 Why?
Tumor Burden2202418920.170 Why?
Gallium Radioisotopes120191950.150 Why?
Lymphoma2202419010.150 Why?
Methotrexate1202417190.140 Why?
Peripheral Nervous System Neoplasms120171330.140 Why?
Glioblastoma2202434830.130 Why?
Prognosis52024296290.130 Why?
Neoplasm Recurrence, Local2202492800.120 Why?
Neurodegenerative Diseases1202210880.110 Why?
Sarcoma1202418010.100 Why?
Pancreas1201916910.100 Why?
Humans1920247615960.090 Why?
Survival Rate12024127230.090 Why?
Tomography, X-Ray Computed42024205680.090 Why?
Epilepsy1202432900.080 Why?
Head and Neck Neoplasms2202428940.080 Why?
Retrospective Studies42024806470.070 Why?
Middle Aged720242209210.070 Why?
Aged620241693100.060 Why?
Follow-Up Studies22024391060.060 Why?
Radiotherapy Planning, Computer-Assisted2202416600.060 Why?
Aged, 80 and over32024589840.060 Why?
Diagnosis, Differential12020129730.060 Why?
Prospective Studies32024544230.060 Why?
Male720243608460.050 Why?
Image Processing, Computer-Assisted1202090010.050 Why?
France120244970.050 Why?
Carcinoma, Squamous Cell1201740240.050 Why?
Dacarbazine120245590.050 Why?
Antineoplastic Agents, Alkylating120246170.040 Why?
Female620243927050.040 Why?
Antifungal Agents120247530.040 Why?
Observer Variation1202426060.040 Why?
Neoplasms12024221730.030 Why?
Soft Tissue Neoplasms1202411590.030 Why?
Reproducibility of Results22024201000.030 Why?
Tissue Distribution1201922640.030 Why?
Oligopeptides1201911870.030 Why?
Adult420242212100.020 Why?
Neoplasm Invasiveness1201735970.020 Why?
Prevalence12024157330.020 Why?
Sensitivity and Specificity12022146650.020 Why?
Brain22023271210.020 Why?
Pilot Projects1201786330.010 Why?
Cell Proliferation12019104510.010 Why?
Proportional Hazards Models12017124630.010 Why?
Cell Line, Tumor12019169900.010 Why?
Lung Neoplasms12024133810.010 Why?
Case-Control Studies12017221760.010 Why?
Disease Models, Animal12019182550.010 Why?
Risk Factors12024742130.010 Why?
Treatment Outcome12019646850.010 Why?
Mice12019815390.010 Why?
Animals120191684750.000 Why?
Rozenblum's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (73)
Explore
_
Co-Authors (4)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.